Search Weight Loss Topics:

Page 951«..1020..950951952953..960970..»

What Is The Ayurvedic Diet? Pros, Cons, And How It Works – Women’s Health

Posted: March 2, 2020 at 11:43 am

If you're into wellness (and since you're reading this, I'm guessing you are!), you've probably heard the term Ayurveda thrown around. You may have even heard of it used when talking about diets and healthy eating. The Ayurvedic diet has been practiced in India for centuries but its only recently caught on in the U.S. While you might have heard it mentioned here and there, its totally understandable that you might be fuzzy on what, exactly, its all about.

Ayurveda is an ancient Indian medical practice, and it focuses on healing the mind and body in a holistic way. The Ayurvedic diet in particular is all about finding the best approaches to food based on your body type, known as a dosha, explains Jessica Cording, RD, author of The Little Book of Game-Changers: 50 Healthy Habits For Managing Stress & Anxiety.

Each body type has a particular name and, according to the principles of the Ayurvedic diet, following the general rules of your dosha should help make you healthy. Its a holistic approach to the best eating pattern for you, Cording says.

Gwyneth Paltrow, Jennifer Aniston, and Julia Roberts have all reportedly followed an Ayurvedic diet at some point. But whats the deal with this diet andmore importantlyis it effective and safe to try? Heres what you need to know.

The Ayurvedic diet leans heavily into the idea that everyone has a dominant dosha, or body type. Once you figure out your dominant dosha, you can adjust your eating plan to meet your health needs, Cording explains. You can determine your dosha by taking a quiz, like this one, and these quizzes are pretty easy to find online or in books about the Ayurvedic diet.

What you eat can help put your dosha into balance; eat the wrong stuff, and youre not living up to your health potential.

Well, the Ayurvedic diet isnt just about eating for your doshathere are some basic principles to keep in mind that apply to everyone.

The diet stresses that there are six tastessweet, sour, salty, pungent, astringent, and bitterand that each one can impact your physiology, or your bodys ability to function properly, Cording says. These are the other principles of the Ayurvedic diet that every dosha should follow:

Ayurveda Cooking for Beginners: An Ayurvedic Cookbook to Balance and Heal

Theres no one manual to the Ayurvedic diet, but there are a few books and people you can look into if youre interested in learning more.

A few books to have on your radar:

The Ayurvedic Institute, which is considered the leading Ayurvedic school in the west, also regularly offers up tips on Instagram. Looking for grammable recipes? Nutritionist Rahi Rajput has got you covered.

The Ayurvedic diet recommends honoring your bodys individual needs, and that can be a good thing. Under the Ayurvedic diet, you shouldnt feel like you have to do the same thing as everyone else. I really appreciate that, Cording notes.

Being more mindful of how much you eat and how quickly you eat could also help with weight loss. And some research backs this up. A review in the International Journal of Obesity showed that following Ayurvedic principles resulted in clinically significant weight loss compared to a placebo. Additionally, an Ayurvedic and yoga-based lifestyle modification program was shown to be an effective method of weight management, according to a study from the University of New Mexico and the University of Arizona. Still, it's hard to say exactly what aspect of the diet leads to weight loss.

As with any diet, the way you approach it matters. You have to be mindful of going to extremes, Cording says. Meaning: While it might be great for you eat to fresh veggies because youre a Pitta, for example, only having these isnt going to help you meet your nutritional needs.

Portion sizes also matter, Cording says, and eating too much of any foodeven if its good for your doshacan make you gain weight. It's also important to recognize that your dosha is based off a self-assessment or assessment of an Ayurvedic doctornot medical testing. That means the reading might not be accurate, and many people feel they're a combination of multiple doshas.

Cording stresses the importance of paying attention to your body on this diet. If you notice that you dont feel well when you eat a particular way for your dosha, you should honor what feels good for your body and change your eating plan, she says.

Overall, Cording recommends checking out the Ayurvedic dietor some form of itif youre looking for a healthier way to approach eating. It can be a useful tool, she says.

The bottom line: Whether you subscribe to the concept of eating for your dosha or not, being more mindful of what foods you eat and how they impact your body and how you feeland tweaking your diet based on thatis definitely a good thing. If the Ayurvedic diet helps you do that, that's a win.

Link:
What Is The Ayurvedic Diet? Pros, Cons, And How It Works - Women's Health

Why swimming is the best cardio exercise – The Massachusetts Daily Collegian

Posted: March 2, 2020 at 11:43 am

Hitting the pool is the best bang for your buck

Ive always been a big fan of the water. At six months old, I took the first plunge into the pool and have been in love with swimming ever since. Whether it was participating on the swim team, swimming in the ocean or enjoying a few recreational laps, the activity has always been near and dear to my heart.

Swimming makes me feel a rich mixture of varying emotions. The feeling of cool water rushing on me makes me feel incredibly at peace; the splashing of the water simultaneously induces a jolt of energy rush through me. Through swimming, I find refuge after a long day of work and studying.

I strongly recommend swimming to everyone because of its extraordinary benefits. The activity offers a wide range of advantages that other cardio activities like running and kickboxing can simply not compete with a perfect combination of muscle building and cardio gains, comfort and a low amount of strain.

Swimming truly is the best cardio exercise for building a great figure. The activity burns a significant amount of calories, making it a great fat burner: doing the freestyle or butterfly stroke burns 300 and 450 calories, respectively. Not only does the activity help with weight loss, but it also aids in maintaining and strengthening muscles. It works every single muscle across your body from your arms to your back to your legs, and the fact that water is far more resistant than air allows you to make significant gains quickly. If you want to concentrate on a particular part of the body, there are a variety of easy-to-use equipment to help you in your goal. For instance, for building up the legs and core, you can use a kickboard. If you want to help get ripped chest and arms, you can put a pull buoy between your legs to isolate those muscles. If you are bored with just your body weight, you can try adding some weights to your routine like adding light weights to your ankles to spice it up.

Critics of swimming point out that other cardio exercises are much better at fat loss than swimming. Running, for instance, burns far more calories on average than swimming, cycling or downhill skiing. Although running and some other cardio activities may offer better fat burning results, they neglect the muscle building component that is critical to a balanced workout with both strength and cardiovascular benefits. Long-distance running actually hurts strength gains because it shrinks muscle fibers. Although other versions of running, particularly sprinting, can lead to good muscle gains, they lack the whole body benefits of swimming because they just concentrate on the lower body predominantly.

The other big benefit of swimming is it is a fairly comfortable exercise to do. Because the water temperature is generally kept around 77 to 82 degrees Fahrenheit, your body is working out in perfect temperature that is neither too hot or too cold: you wont be sweating or shivering to death. In the case of other cardio activities, on the other hand, it could get really uncomfortable really quickly. Imagine dancing or riding a bike while being covered in an ocean of sweat. Moreover, exercising too much, especially in high amounts of heat, could lead to heat exhaustion, whose symptoms include nausea and even fainting. Fortunately, swimming prevents heat exhaustion due to the moderate temperature the pool would be in.

The last great benefit of swimming is the low impact on the joints. Because you wouldnt be slamming your body against hard ground while swimming, the stress on bones, ligaments and tendonsare minimal: thats why many doctors recommend the activity for people with injuries and ailments like arthritis and multiple sclerosis.

While exercising, it is important to make sure you follow a regime that strengthens the body in the long-term rather than obtaining short-term gains and long-time complications as in other cardio options. Kickboxing, which involves kicking heavy bags and people as well as jumping motions, is especially hard on the knees. Running does not help either: a whopping 79 percent of runners will develop some sort of injury annually due to the high-impact nature of the sport.

With all the combined benefits of the sport, swimming clearly ranks king of all other cardio activities. Understanding these benefits makes it clear why swimming is the most popular recreational activity among children and adolescents and the fourth most popular recreational activity overall in the United States, besides the fact that it is really enjoyable to do. So, its time for you to grab some swim gear and a towel and hit the nearest pools near you: check out the swim times at Curry Hicks Cage and Boyden Gymnasium here. If you ever need a swim buddy, you can catch me at Curry Hicks on Tuesdays and Thursdays. I have a couple of great partner drills in mind.

Arnav Mehra is a Collegian columnist and can be reached at [emailprotected].

Continued here:
Why swimming is the best cardio exercise - The Massachusetts Daily Collegian

Yes, Stress Really Is Making You Sick – Newsweek

Posted: March 2, 2020 at 11:43 am

In the mid-2000s, Dr. Nadine Burke Harris opened a children's medical clinic in the Bayview section of San Francisco, one of the city's poorest neighborhoods. She quickly began to suspect something was making many of her young patients sick.

She noticed the first clues in the unusually large population of kids referred to her clinic for symptoms associated with attention deficit hyperactivity disorderan inability to focus, impulsivity, extreme restlessness. Burke Harris was struck not just by the sheer number of ADHD referrals, but also by how many of the patients had additional health problems. One child arrived in her clinic with eczema and asthma and was in the 50th percentile of height for a 4-year-old. He was 7. There were kindergarteners with hair falling out, two children with extremely rare cases of autoimmune hepatitis, middle-school kids stricken with depression and an epidemic number of kids with behavioral problems and asthma.

Burke Harris noticed something else unusual about these children. Whenever she asked their parents or caregivers to tell her about conditions at home, she almost invariably uncovered a major life disruption or trauma. One child had been sexually abused by a tenant, she recalls. Another had witnessed an attempted murder. Many children came from homes struggling with the incarceration or death of a parent, or reported acrimonious divorces. Some caregivers denied there were any problems at all, but had arrived at the appointment high on drugs.

Although none of her mentors at medical school back in the early 2000s had suggested that stress could cause seemingly unrelated physical illnesses, what she was seeing in the clinic was so consistentand would eventually so alarm herit sent her scrambling for answers.

"If I were a doctor, and I was seeing incredibly high rates of autism, I'd be doing research on autism," she says. "Or if I saw incredibly high rates of certain types of cancer, I'd be doing that research. What I was seeing was incredibly, incredibly high rates of kids who were experiencing adversity and then having really significant health outcomes, whether it was difficulty learning, or asthma, or weird autoimmune diseases. I was seeing that the rates were highest in my kids who were experiencing adversity. And that drove me to the latest scientific literature."

What Burke Harris found there would eventually thrust her to the forefront of a growing movement that aims to transform the way the medical profession handles childhood adversity. Childhood stress can be as toxic and detrimental to the development of the brain and body as eating lead paint chips off the wall or drinking it in the waterand should be screened for and dealt with in similar ways, in Burke Harris' view. As California's first Surgeon General, a newly created position, she is focusing on getting lawmakers and the public to act.

Earlier this year, thanks in part to her advocacy, California allocated more than $105 million to promote screening for "Adverse Childhood Experiences" (ACEs)10 family stressors, first identified in the late 1990s, that can elicit a "toxic stress response," a biological cascade driven by the stress hormone cortisol that is linked to a wide range of health problems later in life.

In recent years, epidemiologists, neuroscientists and molecular biologists have produced evidence that early childhood experiences, if sufficiently traumatic, can flip biological switches that can profoundly affect the architecture of the developing brain and long-term physical and emotional health. These "epigenetic" changesmolecular-level processes that turn genes on and offnot only make some people more likely to self-medicate using nicotine, drugs or alcohol and render them more susceptible to suicide and mental illness later in life. They can impair immune system function and predispose us to deadly diseases including heart diseases, cancer, dementia and many others, decades later. Not only does childhood stress harm the children themselves, but the effects may also be passed down to future generations.

A groundswell of support has arisen in the world of public health in favor of treating childhood adversity as a public health crisis that requires interventiona crisis that seems to run in families and repeat itself in trans-generational cycles. At last count, at least 25 states and the District of Columbia had passed statutes or resolutions that refer to Adverse Childhood Experiences. Since 2011, more than 60 state statutes aimed at ACEs or intervening to mitigate their effects have been enacted into law, according ACEs Connection, a website devoted to tracking the phenomenon and providing resources. California's effort is among the most aggressive. The state has set aside $50 million for next year to train doctors to provide screening, and $45 million to begin reimbursing doctors in the state's MediCal program for doing so ($29 for each screening). If it proves effective, other states may soon follow.

"The social determinants of health are to the 21st century, what infectious disease was to the 20th century," says Burke Harris. She rose to national prominence after writing a 2018 book on the subject, embarking on a national book tour and recording a TED Talk that has been viewed more than 6 million times. She was tapped for her new post by Governor Gavin Newsom in January 2019.

The research is so fresh that many clinicians are still debating the best way to tackle the problem, most significantly whether the science is mature and the interventions effective enough to implement universal screening. And the details of California's approach to screening are controversial in the world of public health. (The epidemiologist who developed a key questionnaire being used as a screening tool says it was never intended to be used to evaluate individuals.) But there is broad consensus, at least, about one thing. For all the buzz in public health and policy circles about "ACEs," few people have heard the term before. The first task, many people on the front lines of health education agree, will be to change that so that caregivers themselves can learn about the vicious cycle of childhood adversity, and get the help they need to break it.

The Science of Toxic StressThe research on ACE stems from a seminal 17,000-person epidemiological study published in 1998. The first clue came years earlier, however, with the plight of an obese, 29-year-old woman from San Diego named Patty.

Over the course of a 52-week trial of a weight-loss diet, Patty dropped from 408 lbs. all the way down to 132. Then, over a single three-week period, she abruptly gained 37 pounds of it backa feat that her doctors didn't even know was scientifically possible.

Patty's dramatic weight swings got the attention of Vincent Felitti, the head of the preventative medicine program at the massive managed care consortium Kaiser Permanente, and the man who had designed the obesity study. Felitti had been astounded at the rapid pace with which the study subjects lost weight. "In the early days of the obesity study, I remember thinking 'wow, we've got this problem licked,'" Felitti recalls. "This is going to be a world-famous department!"

Then, for reasons nobody could explain, patients began dropping out of the program in droves. Felitti found it particularly alarming because the ones leaving the fastest seemed to be the ones losing the most weight. When Felitti heard about Patty, he arranged a chat. Patty claimed she was just as mystified by her massive weight gain as he was; she assured him she was still vigilantly sticking to the diet. But then she offered up a suggestive clue: Every night when she went to bed, she told Felitti, the kitchen was clean. Yet when she woke up, there were boxes and cans open and dirty dishes in the sink. Patty lived alone and had a history of sleepwalking. Was it possible, she wondered, that she was "sleep eating?"

When Felitti asked her if anything unusual had happened in her life around the time the dirty pots and pans began to appear, one event came to mind. An older, married man at work had told her she looked great and suggested they have an affair. After further questioning, Felitti learned Patty had first started gaining weight at age 10, around the time her grandfather began sexually molesting her.

Felitti came to believe that for Patty, obesity was an adaptive mechanism: she overate as a defense against predatory men. Felitti began asking other relapsing study participants if they had a history of sexual abuse. He was shocked by their answers. Eventually, more than 50 percent of his 300 patients would admit to such a history.

"Initially I thought, 'Oh, no, I must be doing something wrong. With numbers like this, people would know if this were true. Somebody would have told me in medical school,'" he recalls.

Felitti started bringing patients together in groups to talk about their secrets, their fears and the challenges they facedand their weight loss began to stick. Within a couple years, the program was so successful that Felitti was receiving regular invitations to speak about his program to medical audiences. Whenever he brought up sexual abuse and its apparent link to obesity, however, audience members would "storm explosively" out of the room or stand up to argue with him, he says. Nobody, it seemed, wanted to hear what he had to say.

At least one person was intrigued by his findings. Robert Anda, a researcher at U.S. Centers for Disease Control (CDC), had been studying chronic diseases and the counterintuitive links between depression, hope and heart attacks. He knew firsthand what it was like to deal with colleagues who considered his work flaky. Anda and Felitti got to talking. They realized there was only one way that both of them would be able to overcome the skepticism they were encountering: they needed to do a rigorous study. At Anda's urging, Felitti agreed not just to recruit a larger sample but to expand its scope to examine the link between a wide array of common childhood stressors and health later in life.

This became the ground-breaking "ACE Study," a 17,000-person retrospective project aimed at examining the relationship between childhood exposure to emotional, physical and sexual abuse and household dysfunction, and risky behaviors and disease in adulthood. Starting in 1998, and continuing with follow-ups well into the 2000s, Felitti and Anda's team published a series of counterintuitive papers that upended much of what we thought we knew about the mind-body connection.

To gather the data, Felitti persuaded Kaiser Permanente-affiliated doctors to recruit patients in Southern California undergoing routine physical exams. The patients were asked to complete confidential surveys detailing both their current health status and behaviors, and the types of adversity they've endured: physical, emotional and sexual abuse, neglect, domestic violence, parental incarceration, separation or divorce, family mental illness, the early death of a parent, alcoholism and drug abuse. To analyze the data, the researchers added up the number of ACEs, calculated an "ACE score," then correlated those scores with high-risk behaviors and diseases to see if they could find any patterns.

The first shocker was just how common these ACEs were. More than half of those participating had at least one, a quarter had two or more and roughly 6 percent reported four or more. This was not just a problem of the poor. Childhood emotional adversity cut across all racial, ethnic and economic lines. Even more surprising was the impact of these stressors later in life. When the researchers ran their analysis, they discovered a direct, dose-dependent link between the number of ACEs and behavioral issues like alcoholism, smoking and promiscuitythose who had experienced four or more categories of childhood exposure had a four- to 12-fold increased risk of alcoholism, drug abuse, depression and suicide attempts.

The results went beyond these common trauma-related health risks. The study also linked childhood trauma to a host of seemingly unrelated physical problems, including ischemic heart disease, cancer, chronic lung disease, skeletal fractures and liver disease.

What made the study so shocking was that the data suggested that even those who didn't drink, use drugs or act out in risky ways still had a far higher rate of developing ischemic heart disease, cancer, chronic lung disease, skeletal fractures and liver disease. Unexpectedly, the researchers had discovered that childhood adversity seemed to be an independent risk factor for some of the leading causes of death decades later.

"We found a strong graded relationship between the breadth of exposure to abuse or household dysfunction during childhood and multiple risk factors for several of the leading causes of death in adults," the authors wrote.

The study dropped like a bomb in the world of public health. But the scientific work was just beginning. In the years since, scores of researchers have begun to dig into the biological mechanisms in play. And with emerging brain scanning technologies and advances in molecular biology, an explanation for the ACE study has begun to emerge. Some clinicians and scientists have begun to turn these findings into concrete interventions and treatments they hope can be used to reverse or at least attenuate the impact.

Much of the research has focused on how ACEs affect the functioning of the hypothalamic-pituitary-adrenal (HPA) axis, a biological system that plays a key role in the mind-body connection. The HPA axis controls our reactions to stress and is crucial in regulating an array of important body processes including immune function, energy storage and expenditureeven our experience of emotions and mood. It does so by adjusting the release of key hormones, most notably cortisol, the release of which is increased by stress or low blood sugar levels.

Cortisol has many functions. On a daily basis, it regulates the level of energy we have as the day progresses: we generally experience our highest levels of cortisol, and energy, upon waking up. These levels gradually diminish throughout the day, reaching very low levels just prior to bedtime.

Cortisol also serves a role in the body's energy allocation during times of crisis. When all is calm, the body builds muscle or bone and socks away excess calories for future consumption as fat, performs cellular regeneration and keeps its immune system strong to fight infection. In the case of a child, the body fuels normal mental and physical development.

In an emergency, however, all these processes get put on hold. The HPA axis floods the bloodstream with adrenaline and cortisol, which signals the body to kick into overdrive immediately. Blood sugar levels spike and the heart pumps harder to provide a fast boost in fuel. If an 11-foot-tall grizzly bear is lumbering in your direction and licking his chops, the additional burst of energy helps you run screaming through the woods or wrestle the critter to the ground and plunge a Bowie knife into its heart.

However, when the emergency goes on for a long timeperhaps over an entire childhood of abusethe resulting high levels of cortisol take a big and lasting toll.

Almost as soon as the ACE study was published, dysregulated cortisol levels seemed a likely culprit to explain the study's startling implications. Was it possible that the chronic stressors identified by Felitti and Anda led to elevated cortisol levels in children? And could those elevated levels account for seemingly unrelated diseases and the range of additional problems that researchers were beginning to link to ACEs?

In the decade after the 1998 ACE study, researchers began seeking out children in Romanian orphanages and measuring cortisol levels, in the hopes of verifying this hypothesis. When researchers began to compare their levels to that of children who had not faced adversity, they found substantial differences. But the results were difficult to interpret.

"There was growing evidence that there was an impact, but the studies were contradictory," says Jackie Bruce, a research scientist at the Oregon Social Learning Center, an NIH-funded research center in Eugene that studies child development. "Sometimes people were finding kids with early adversity had low cortisol and sometimes they were finding they had high cortisol."

In 2009, Bruce and her colleagues demonstrated a possible explanation for the discrepancies. Since morning cortisol levels play such an important role in getting well-functioning individuals ready for the day, they sought out a group of 117 maltreated 3- to 6-year-old children transitioning into new foster care placements in the United States. The researchers then trained the children's caregivers to collect saliva samples before breakfast. For comparison, they recruited a control group of 60 low-income children living with their biological parents who had no previous record of abuse or maltreatment.

Children who had experienced more severe emotional, physical and sexual maltreatment did indeed have abnormally high morning cortisol levels. But scientists also found that children who experienced more severe neglect had abnormally low morning cortisol levels. Different types of adversity, in other words, had different impacts on the HPA system. But whether the adversity took the form of an absence of stimulation or the presence of negative, threatening stimulation, the effect was bad for normal development.

"Low cortisol levels, particularly in the morning, had been linked to externalizing disordersthings like delinquency and alcohol usewhereas high cortisol levels have been linked to more anxiety and depression," and post-traumatic stress disorder, Bruce says.

Even so, Bruce and her colleagues noted that within both groups, "some kids are doing really well, some kids are not doing well." This suggested other factors were also involved. And in recent years, much of the research has focused on understanding the complex interaction between external stressors, genetics and interpersonal interventions.

One of the most important findings to emerge recently is that the experience of childhood adversity, by itself, does not appear to be enough to lead to toxic stress. Genetic predispositions play a role. But even among those predisposed, the effects can be blunted by what researchers call emotional "buffering"a response from a loving, supportive caregiver that comforts the child, restores a sense of safety and allows cortisol levels to fall back down to normal. Some research suggests that this buffering works in part because a good hugor even soft reassuring words from a caregivercan cause the body to release the hormone oxytocin, sometimes referred to as the "cuddle" or "love" hormone.

One of the reasons the ACE study was so effective at highlighting the potential long-term health effects that early childhood adversity can have on health, says Burke Harris, was the nature of the stressors measured. The stressors took place within the context of a family situation that often reflected the failure of a caregiver to intervene as a needed protector.

"The items that are on the ACE screening have this amazing combination of being high stress and also simultaneously taking out the buffering protected mechanisms," Burke Harris says. "If you're being regularly abused, often it's partially because your parents are not intervening."

This hypothesis is supported by experiments in rodents. Back in the 1950s, the psychiatrist Seymour Levine demonstrated that baby rats taken away from their mothers for 15 minutes each day grew up to be less nervous and produce less cortisol than their counterparts. The reason, he suggested, was due to affection from their distressed parent in the form of extra licking and grooming. Studies in the 1990s confirmed that the extra affection and comfort offered by the affectionate parents seemed to have flipped biological "epigenetic" switches that caused their offspring to internalize the sense of safety that had been provided and replicate it biochemically as adults.

Scientists have since documented many biochemical mechanisms by which emotional buffering can help inoculate children exposed to adversity to long-term consequences, and how chronic overactivation of the HPA axis can interfere with developmentor, as one widely cited scientific paper put it, can have an impact akin to "changing the course of a rocket at the moment of takeoff." Neglected and abused Romanian orphans were shown to have smaller brains as a population than those placed in loving foster homes, suggesting a lack of stimulation interfered with normal neuronal growth. Adversity and stress without adequate buffering can turn on genes that flood the system with enzymes that prime the body to respond to further stress by making it easier to produce adrenaline and reactivate the fight-or-flight response quickly, which can make it harder for children with toxic stress to control their emotions.

Toxic stress can also have powerful influences on the developing immune system. Too much cortisol suppresses immunity and increases the chance of infection, while too little cortisol can cause an inflammatory immune response to persist long after it is needed. That can act directly on the brain to produce "sickness behavior," characterized by a lack of appetite, fatigue, social withdrawal, depressed mood, irritability and poor cognitive functioning, according to a 2013 review paper aimed at bringing pediatricians up to speed on the emerging science. As adults, children maltreated during childhood are more likely to have elevated inflammatory markers and a greater inflammatory response to stress, the researchers reported. Chronic elevations in cortisol have also been linked to hypertension, insulin resistance, obesity, type 2 diabetes and cardiovascular disease.

In recent years, Fellitti and Anda's original 1998 paper has been cited more than 10,000 times in further studies. And as awareness in the public health community has risen, so too has the amount of data available to work with, and the vast body of research documenting the far-reaching consequences of ACEs. Last fall, the CDC analyzed data from 25 states collected between 2015 and 2017, and more than 144,000 adults (a sample 8.5 times larger than the original 1998 study). The authors noted that ACEs are associated with at least five of the top 10 leading causes of death; that preventing ACEs could potentially reduce chronic diseases, risky health behaviors and socioeconomic challenges later in life and have a positive impact on education and employment levels. Reducing ACEs could prevent 21 million cases of depression; 1.9 million cases of heart disease; and 2.5 million cases of obesity, the authors said.

Hundreds of new studies are published every year. In just the last month, studies have come out analyzing the "mediating role of ACEs in attempted suicides among adolescents in military families," the impact of ACEs on aging and on "deviant and altruistic behavior during emerging adulthood."

How to Save the KidsWhile these findings help explain the link to chronic diseases, Harris Burke and other public health officials believe they also provide the basis for some of the most promising interventions in the clinic today. Not surprisingly given her background, Burke Harris looks to pediatric caregivers and other doctors to lead the effort to detect and treat patients suffering from toxic stress. To help them do it, late last year, California released a clinical "algorithm": basically a chart spelling out how doctors should proceed once they compiled a patient's ACE score.

Patients are found to be high-risk for negative health outcomes if the doctor, using a questionnaire, can identify four or more of the adverse childhood experiences or some combination of psychological, social or physical conditions found in studies to be associated with toxic stress. For children, that's obesity, failure-to-thrive syndrome and asthma, but also other indicators such as drug or alcohol use prior to the age of 14, high-school absenteeism and other social problems. For adults, the list includes suicide attempts, memory impairment, hepatitis, cancer and other conditions found to be higher in populations with high ACE scores.

Doctors are encouraged to educate all patients about ACEs and toxic stress regardless of their ACE scores. For patients found to be at intermediate or high risk, additional steps are recommended. The first step in the case of children is to make sure parents or caregivers understand the links ACEs can have to adverse health outcomes. That way, they can be on the lookout for new conditions and take action to prevent them.

Key to this educational process is making sure caregivers understand the protective role buffering can play in countering the corrosive effects of stress. Buffering includes nurturing caregiving, but it can include simple steps like focusing on maintaining proper sleep, exercise and nutrition. Mindfulness training, mental health services and an emphasis on developing healthy relationships are other interventions that Burke Harris says can help combat the stress response.

The specifics will vary on a case-by-case basis, and will rely on the judgment and creativity of the doctor to help adult caregivers design a plan to protect the childand to help both those caregivers and high-risk adults receive social support services and interventions when necessary. In the months ahead, the protocols and interventions will be further refined and expanded. "Most of our interventions are essentially reducing stress hormones, and ultimately changing our environment," says Burke Harris. "But some of the things that I think are really exciting are on the horizon."

In recent years researchers have begun to explore whether the "love drug," oxytocina hormone released when a parent hugs a child might form the basis for potent pharmaceutical interventions. For now, however, "we're on the scientific frontier," she says.

The relatively young state of the science and the fuzziness and subjective nature of the tools California plans to use to evaluate the threat have alarmed some public-health experts. They worry that the state is moving too fast, before more is known about the science of toxic stress. Robert Anda, for one, is uncomfortable with the use of screening tools that rely on an ACE score. He worries it might be misused in the doctor's office because it doesn't measure caregiver buffering or genetic predispositions that might prove protective. The questionnaire he and Felitti developed for the original study was always meant to be a blunt instrumentsuited for a survey of a huge population of patients. The problem with applying it to individual patients, he says, is that it doesn't take into account the severity of the stressor. Who's to say, for instance, that someone with an ACE score of one who was beaten by a caregiver every day of their life is less prone to disease than someone with an ACE score of four who experienced these stressors only intermittently? On a population level, surveying thousands, the outliers would cancel each other out. But on the individual level they could be misleading.

It's a concern echoed by others. "I think the concept behind ACE screening, if it's about sensitizing all of us to the importance of looking for that part of the population that's experiencing adversity, I'd say that's good," says Jack Shonkoff, a professor of child health and development who directs the Center on the Developing Child at Harvard University. "But if it's used as an individual diagnostic test or indicator child by child, I would say that's potentially dangerous in terms of inappropriate labeling or inappropriate alarm. We need to make sure that people don't misuse this information so that parents don't feel like they've just been given some kind of deterministic diagnosis. Because it's not that. It's also dangerous to totally give a clean bill of health for a kid who may be showing symptoms of stress."

Burke Harris notes that she has been using ACE scores as part of her clinical care for more than a decade. When used correctly, it is only one part of a larger screening process. And she points out that despite the early phase of the field, the stakes are too high to wait any longer. "This is extremely urgent," she says. "It's a public health crisis. We have enough research now to act. And once we have enough research to act, not acting becomes an unconscionable path."

In the years ahead, more precise methods of detection will likely be available. Harvard's Shonkoff recently completed a large, nationwide feasibility study aimed at developing and rolling out a saliva test which could be used to screen for biomarkers that indicate a toxic stress response in both children and adults. The test, developed as part of a six-year, $13 million grant, measures the level of inflammatory cytokines present in the spit sample. Shonkoff and his colleagues are in the process of taking the next step, which involves gathering enough data to develop benchmarks that indicate normal and abnormal levels for stress markers by age, sex, race and ethnicity.

Even the cautious agree a little education will go a long way. "The most important fundamental prevention idea is that people who are caring for children, who are parenting children, need to understand that childhood adversities are likely leading to issues in their own lives," Shonkoff says. "And if they don't find a way to do things differently with support, they will be embedding that same biology back in their children."

Read the original post:
Yes, Stress Really Is Making You Sick - Newsweek

6 powerful benefits of tea – KUTV 2News

Posted: March 2, 2020 at 11:43 am

You have probably heard that drinking at least one cup of tea a day is good for you. You may also have heard that tea is filled with antioxidants, making it ideal for fighting off colds or viruses. A hot cup of tea is a great way to start your morning if you're not a coffee drinker, and if nothing else, it keeps you warm in cold weather.

There's more to drinking tea than you think. What many people don't know is that tea has many other health benefits too.

A brief tea history

Tea originally began as a tradition and ritual in China. It was used more for medicinal purposes and less for enjoyment. As the tradition of drinking tea spread from China to Japan and then to the rest of Europe, it quickly became a popular beverage consumed by millions around the world. People not only enjoy tea for its delightful taste but its health and therapeutic benefits.

Different types of tea

Caffeinated teas derive from the Camellia Sinensis plant. Black tea, green tea, white tea, and oolong tea are the most popular caffeinated brews consumed by Americans. The taste varies based on how the plant is processed. Caffeine levels depend on how long you steep your tea.

Herbal teas, on the other hand, are made from roots, leaves, flowers, and components of different plants. Some popular herbal teas are chamomile and peppermint.

Here are more awesome nutritious benefits that come with drinking tea.

1. Rich in antioxidants

Do you ever wonder why your mother suggests drinking tea when you have a cold? This is because tea, specifically black and green tea, is known for packing a powerful punch of antioxidants. These drinks contain polyphenols that help remove free radicals and decrease cell damage. The warm tea is also very soothing for a sore throat.

2. It's good for your teeth

Has your dentist told you to cut back on soda and juice due to the high amounts of sugar? Do you feel like water is your only option when it comes to beverages? Green tea, specifically, contains an antioxidant called polyphenol, which can protect against oral diseases, such as gingivitis, and periodontal disease.

3. Tea may improve your gut health

Your gut is more important than you think. Your gut contains trillions of bacteria, according to Healthline. The bacteria in your gut help reduce the risk of different health conditions, such as type 2 diabetes, obesity, and cancer. However, some of those bacteria are not good for you. Studies show that the polyphenols found in black tea may help promote the growth of good bacteria, increasing the overall health of your gut.

4. Tea is anti-inflammatory

Inflammation is the body's response to injury and infection, according to Live Science. Chronic inflammation has linked to heart disease or stroke. Once again, the polyphenols in tea can help fight inflammation. Studies show that the epigallocatechin gallate (EGCG) in green tea has anti-inflammatory effects.

5. It may help with weight loss

More than half of Americans begin their new year with a goal of weight management. Some studies suggest that the caffeine and catechins of caffeinated teas, such as black tea and green tea, may help people lose a pound or two.

6. It increases focus

Everyone has those days where they have a hard time staying focused. Regularly consuming black and green tea can prevent cognitive decline by boosting memory and increasing attention span.

According to the Academy of Nutrition and Dietetics, both caffeinated and herbal tea may also provide small amounts of potassium, phosphorous, magnesium, sodium, copper, and zinc.

This article is for informational purposes only and is not intended to diagnose or treat any condition. If you have any concerns, please speak with your doctor.

Sinclair Broadcast Group is committed to the health and well-being of our viewers, which is why we initiated Sinclair Cares. Every month we'll bring you information about the "Cause of the Month," including topical information, education, awareness, and prevention. March is National Nutrition Month.

Go here to read the rest:
6 powerful benefits of tea - KUTV 2News

Karyopharm Announces Phase 3 BOSTON Study Meets Primary Endpoint with Significant Increase in Progression-Free Survival in Patients with Multiple…

Posted: March 2, 2020 at 11:43 am

Combination of Once-Weekly XPOVIO (selinexor), Once-Weekly Velcade (bortezomib) plus Dexamethasone (SVd) Results in Statistically Significant Reduction in the Risk of Disease Progression or Death Compared to Standard Twice-Weekly Velcade plus Dexamethasone (Vd) Regimen

47% Increase in Median PFS on SVd versus Vd

Regulatory Submission Planned in 2Q 2020; Data to be Submitted for Presentation at Upcoming Medical Meetings

Management to Host Conference Call Today at 8:30 AM ET

NEWTON, Mass., March 02, 2020 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced positive top-line results from the randomized Phase 3 BOSTON study evaluating once-weekly XPOVIO (selinexor) in combination with once-weekly Velcade (bortezomib) and low-dose dexamethasone (SVd) compared to standard twice-weekly Velcade plus low-dose dexamethasone (Vd) in patients with multiple myeloma who have received one to three prior lines of therapy. The BOSTON study met its primary endpoint of a statistically significant increase in progression-free survival (PFS). The median PFS in the SVd arm was 13.93 months compared to 9.46 months in the Vd arm, representing a 4.47 month (47%) increase in median PFS (hazard ratio=0.70; p=0.0066). There were no new safety signals on the SVd arm and there was no imbalance in deaths between the two arms in the study. The full top-line data will be submitted for presentation at upcoming medical meetings.

We are thrilled to report these highly significant top-line results from the BOSTON study, the first randomized Phase 3 trial to demonstrate clinically and statistically significant activity of once-weekly XPOVIO in combination with a current standard of care treatment in patients with myeloma after one to three prior therapies, said Sharon Shacham, PhD, MBA, President and Chief Scientific Officer of Karyopharm. In the study, patients on the SVd regimen lived 47% longer without their disease worsening, which we believe represents an important improvement in the treatment of patients with relapsed or refractory multiple myeloma. We plan to submit the full data set for presentations at upcoming medical meetings to share the results with the medical community. We also intend to submit these data as quickly as possible to the U.S. Food and Drug Administration (FDA) as part of a supplemental New Drug Application seeking to expand the approved indication for XPOVIO into second line treatment for patients with relapsed or refractory multiple myeloma. If approved, the SVd regimen would be the first and only FDA-approved combination drug regimen that includes once-weekly Velcade therapy for relapsed myeloma.

XPOVIO received accelerated approval from the FDA on July 3, 2019 for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody. This indication is approved under accelerated approval based on response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. Karyopharm expects to submit data from the Phase 3 BOSTON study to serve as this confirmatory trial. The full Prescribing Information for XPOVIO is available at http://www.XPOVIO.com.

About the BOSTON Study

BOSTON is a Phase 3 randomized, active comparator-controlled, open-label, multicenter study that is designed to compare the efficacy, safety and certain health-related quality of life (HR-QoL) parameters of once-weekly XPOVIO (selinexor) in combination with once-weekly Velcade (bortezomib) plus low-dose dexamethasone (SVd) versus twice-weekly Velcade plus low-dose dexamethasone (Vd) in adult patients with relapsed or refractory multiple myeloma who have received one to three prior lines of therapy. The BOSTON study enrolled approximately 402 patients. The primary endpoint of the study is progression-free survival (PFS) and key secondary endpoints include overall response rate (ORR), among others. Additionally, the BOSTON study allows for patients on the Vd control arm to crossover to the SVd arm following objective (quantitative) progression of disease. The BOSTON study is being conducted at over 150 clinical sites internationally.

Vd is a standard therapy for previously treated patients with multiple myeloma that is given by injection twice-weekly. Unlike other drugs used to treat multiple myeloma, selinexor is taken orally. Patients randomized to the SVd arm received selinexor (100mg once-weekly), Velcade (1.3 mg/m2 once-weekly given subcutaneously) and dexamethasone (40mg weekly). Patients randomized to the Vd arm received Velcade (twice-weekly) plus low-dose dexamethasone (standard therapy given on the recommended schedule).

Conference Call Information

Karyopharm will host a conference call today, Monday, March 2, 2020, at 8:30 a.m. Eastern Time, to discuss the top-line results from the BOSTON study. To access the conference call, please dial (855) 437-4406 (local) or (484) 756-4292 (international) at least 10 minutes prior to the start time and refer to conference 3515858. A live audio webcast of the call will be available under "Events & Presentations" in the Investor section of the Company's website, http://investors.karyopharm.com/events-presentations. An archived webcast will be available on the Company's website approximately two hours after the event.

About Multiple Myeloma

According to the National Cancer Institute (NCI), multiple myeloma is the second most common blood cancer in the U.S. with more than 32,000 new cases each year and over 130,000 patients living with the disease. Despite recent therapeutic advances, there is currently no cure and most patients disease will typically progress following treatment with currently available therapies. According to the NCI, nearly 13,000 deaths due to multiple myeloma were expected in the U.S. in 2019.

About XPOVIO (selinexor)

XPOVIO is a first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) compound. XPOVIO functions by selectively binding to and inhibiting the nuclear export protein exportin 1 (XPO1, also called CRM1). XPOVIO blocks the nuclear export of tumor suppressor, growth regulatory and anti-inflammatory proteins, leading to accumulation of these proteins in the nucleus and enhancing their anti-cancer activity in the cell. The forced nuclear retention of these proteins can counteract a multitude of the oncogenic pathways that, unchecked, allow cancer cells with severe DNA damage to continue to grow and divide in an unrestrained fashion. Karyopharm received accelerated U.S. Food and Drug Administration (FDA) approval of XPOVIO in July 2019 in combination with dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma (RRMM) who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody. Karyopharm has also submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) with a request for conditional approval of selinexor. A supplemental New Drug Application was recently submitted to the FDA seeking accelerated approval for selinexor as a new treatment for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), and selinexor has received Fast Track and Orphan designation from the FDA for this patient population. Selinexor is also being evaluated in several other mid-and later-phase clinical trials across multiple cancer indications, including in multiple myeloma in a pivotal, randomized Phase 3 study in combination with Velcade (bortezomib) and low-dose dexamethasone (BOSTON), as a potential backbone therapy in combination with approved therapies (STOMP), in liposarcoma (SEAL) and in endometrial cancer (SIENDO), among others. Additional Phase 1, Phase 2 and Phase 3 studies are ongoing or currently planned, including multiple studies in combination with approved therapies in a variety of tumor types to further inform Karyopharm's clinical development priorities for selinexor. Additional clinical trial information for selinexor is available at http://www.clinicaltrials.gov.

IMPORTANT SAFETY INFORMATION

Thrombocytopenia

XPOVIO can cause thrombocytopenia, leading to potentially fatal hemorrhage. Thrombocytopenia was reported as an adverse reaction in 74% of patients, and severe (Grade 3-4) thrombocytopenia occurred in 61% of patients treated with XPOVIO. The median time to onset of the first event was 22 days. Bleeding occurred in 23% of patients with thrombocytopenia, clinically significant bleeding occurred in 5% of patients with thrombocytopenia and fatal hemorrhage occurred in <1% of patients.

Monitor platelet counts at baseline, during treatment, and as clinically indicated. Monitor more frequently during the first two months of treatment. Institute platelet transfusion and/or other treatments as clinically indicated. Monitor patients for signs and symptoms of bleeding and evaluate promptly. Interrupt and/or reduce dose, or permanently discontinue based on severity of adverse reaction.

Neutropenia

XPOVIO can cause neutropenia, potentially increasing the risk of infection. Neutropenia was reported as an adverse reaction in 34% of patients, and severe (Grade 3-4) neutropenia occurred in 21% of patients treated with XPOVIO. The median time to onset of the first event was 25 days. Febrile neutropenia was reported in 3% of patients.

Obtain neutrophil counts at baseline, during treatment, and as clinically indicated. Monitor more frequently during the first two months of treatment. Monitor patients for signs and symptoms of concomitant infection and evaluate promptly. Consider supportive measures including antimicrobials for signs of infection and use of growth factors (e.g., G-CSF). Interrupt and/or reduce dose, or permanently discontinue based on severity of adverse reaction.

Gastrointestinal Toxicity

Gastrointestinal toxicities occurred in patients treated with XPOVIO.

Nausea/Vomiting

Nausea was reported as an adverse reaction in 72% of patients, and Grade 3 nausea occurred in 9% of patients treated with XPOVIO. The median time to onset of the first nausea event was 3 days.

Vomiting was reported in 41% of patients, and Grade 3 vomiting occurred in 4% of patients treated with XPOVIO. The median time to onset of the first vomiting event was 5 days.

Provide prophylactic 5-HT3 antagonists and/or other anti-nausea agents, prior to and during treatment with XPOVIO. Manage nausea/vomiting by dose interruption, reduction, and/or discontinuation. Administer intravenous fluids and replace electrolytes to prevent dehydration in patients at risk. Use additional anti-nausea medications as clinically indicated.

Diarrhea

Diarrhea was reported as an adverse reaction in 44% of patients, and Grade 3 diarrhea occurred in 6% of patients treated with XPOVIO. The median time to onset of diarrhea was 15 days.

Manage diarrhea by dose modifications and/or standard anti-diarrheal agents; administer intravenous fluids to prevent dehydration in patients at risk.

Anorexia/Weight Loss

Anorexia was reported as an adverse reaction in 53% of patients, and Grade 3 anorexia occurred in 5% of patients treated with XPOVIO. The median time to onset of anorexia was 8 days.

Weight loss was reported as an adverse reaction in 47% of patients, and Grade 3 weight loss occurred in 1% of patients treated with XPOVIO. The median time to onset of weight loss was 15 days.

Monitor patient weight at baseline, during treatment, and as clinically indicated. Monitor more frequently during the first two months of treatment. Manage anorexia and weight loss with dose modifications, appetite stimulants, and nutritional support.

Hyponatremia

XPOVIO can cause hyponatremia; 39% of patients treated with XPOVIO experienced hyponatremia, 22% of patients experienced Grade 3 or 4 hyponatremia. The median time to onset of the first event was 8 days.

Monitor sodium level at baseline, during treatment, and as clinically indicated. Monitor more frequently during the first two months of treatment. Correct sodium levels for concurrent hyperglycemia (serum glucose >150 mg/dL) and high serum paraprotein levels. Treat hyponatremia per clinical guidelines (intravenous saline and/or salt tablets), including dietary review. Interrupt and/or reduce dose, or permanently discontinue based on severity of adverse reaction.

Infections

In patients receiving XPOVIO, 52% of patients experienced any grade of infection. Upper respiratory tract infection of any grade occurred in 21%, pneumonia in 13%, and sepsis in 6% of patients. Grade 3 infections were reported in 25% of patients, and deaths resulting from an infection occurred in 4% of patients. The most commonly reported Grade 3 infections were pneumonia in 9% of patients, followed by sepsis in 6%. The median time to onset was 54 days for pneumonia and 42 days for sepsis. Most infections were not associated with neutropenia and were caused by non-opportunistic organisms.

Neurological Toxicity

Neurological toxicities occurred in patients treated with XPOVIO.

Neurological adverse reactions including dizziness, syncope, depressed level of consciousness, and mental status changes (including delirium and confusional state) occurred in 30% of patients, and severe events (Grade 3-4) occurred in 9% of patients treated with XPOVIO. Median time to the first event was 15 days.

Optimize hydration status, hemoglobin level, and concomitant medications to avoid exacerbating dizziness or mental status changes.

Embryo-Fetal Toxicity

Based on data from animal studies and its mechanism of action, XPOVIO can cause fetal harm when administered to a pregnant woman. Selinexor administration to pregnant animals during organogenesis resulted in structural abnormalities and alterations to growth at exposures below those occurring clinically at the recommended dose.

Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential and males with a female partner of reproductive potential to use effective contraception during treatment with XPOVIO and for 1 week after the last dose.

ADVERSE REACTIONS

The most common adverse reactions (incidence 20%) are thrombocytopenia, fatigue, nausea, anemia, decreased appetite, decreased weight, diarrhea, vomiting, hyponatremia, neutropenia, leukopenia, constipation, dyspnea, and upper respiratory tract infection.

The treatment discontinuation rate due to adverse reactions was 27%; 53% of patients had a reduction in the XPOVIO dose, and 65.3% had the dose of XPOVIO interrupted. The most frequent adverse reactions requiring permanent discontinuation in 4% or greater of patients who received XPOVIO included fatigue, nausea, and thrombocytopenia. The rate of fatal adverse reactions was 8.9%.

Please see XPOVIO Full Prescribing Information available at http://www.XPOVIO.com.

About Karyopharm Therapeutics

Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's SINE compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Karyopharms lead compound, XPOVIO (selinexor), received accelerated approval from the FDA in July 2019 in combination with dexamethasone as a treatment for patients with heavily pretreated multiple myeloma. An MAA for selinexor is also currently under review by the EMA for the same indication. The Company recently submitted a New Drug Application to the FDA seeking approval for XPOVIO in patients with DLBCL. In addition to single-agent and combination activity against a variety of human cancers, SINE compounds have also shown biological activity in models of neurodegeneration, inflammation, autoimmune disease, certain viruses and wound-healing. Karyopharm has several investigational programs in clinical or preclinical development. For more information, please visit http://www.karyopharm.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those regarding Karyopharms expectations relating to XPOVIO for the treatment of patients with heavily pretreated multiple myeloma or relapsed or refractory diffuse large B-cell lymphoma; commercialization of XPOVIO or any of its drug candidates and the commercial performance of XPOVIO; submissions to, and the review and potential approval of selinexor by, regulatory authorities, including the anticipated availability of data to support such submissions, timing of such submissions and actions by regulatory authorities and the potential availability of accelerated approval pathways; and the therapeutic potential of and potential clinical development plans for Karyopharm's drug candidates, especially selinexor. Such statements are subject to numerous important factors, risks and uncertainties, many of which are beyond Karyopharm's control, that may cause actual events or results to differ materially from Karyopharm's current expectations. For example, there can be no guarantee that Karyopharm will successfully commercialize XPOVIO; that regulators will agree that selinexor qualifies for conditional approval in the E.U. as a result of data from the STORM study or confirmatory approval in the U.S. or EU based on the BOSTON study in patients with relapsed or refractory multiple myeloma, or accelerated approval in the U.S. for patients with relapsed or refractory DLBCL as a result of data from the SADAL study, or that any of Karyopharm's drug candidates, including selinexor, will successfully complete necessary clinical development phases or that development of any of Karyopharm's drug candidates will continue. Further, there can be no guarantee that any positive developments in the development or commercialization of Karyopharm's drug candidate portfolio will result in stock price appreciation. Management's expectations and, therefore, any forward-looking statements in this press release could also be affected by risks and uncertainties relating to a number of other factors, including the following: adoption of XPOVIO in the commercial marketplace, the timing and costs involved in commercializing XPOVIO or any of Karyopharms drug candidates that receive regulatory approval; the ability to retain regulatory approval of XPOVIO or any of Karyopharms drug candidates that receive regulatory approval; Karyopharm's results of clinical trials and preclinical studies, including subsequent analysis of existing data and new data received from ongoing and future studies; the content and timing of decisions made by the U.S. Food and Drug Administration and other regulatory authorities, investigational review boards at clinical trial sites and publication review bodies, including with respect to the need for additional clinical studies; the ability of Karyopharm or its third party collaborators or successors in interest to fully perform their respective obligations under the applicable agreement and the potential future financial implications of such agreement; Karyopharm's ability to obtain and maintain requisite regulatory approvals and to enroll patients in its clinical trials; unplanned cash requirements and expenditures; development of drug candidates by Karyopharm's competitors for diseases in which Karyopharm is currently developing its drug candidates; and Karyopharm's ability to obtain, maintain and enforce patent and other intellectual property protection for any drug candidates it is developing. These and other risks are described under the caption "Risk Factors" in Karyopharm's Annual Report on Form 10-K for the year ended December 31, 2019, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2020, and in other filings that Karyopharm may make with the SEC in the future. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by law, Karyopharm expressly disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Velcade is a registered trademark of Takeda Pharmaceutical Company Limited

Contacts:

Investors: Karyopharm Therapeutics Inc. Ian Karp, Vice President, Investor and Public Relations857-297-2241 | ikarp@karyopharm.com

Media:

FTI ConsultingSimona Kormanikova or Robert Stanislaro212-850-5600 |Simona.Kormanikova@fticonsulting.com or robert.stanislaro@fticonsulting.com

The rest is here:
Karyopharm Announces Phase 3 BOSTON Study Meets Primary Endpoint with Significant Increase in Progression-Free Survival in Patients with Multiple...

People with severe mental illness live shorter lives but the solution isn’t simple – The Conversation UK

Posted: March 2, 2020 at 11:43 am

People with severe mental illness, such as psychosis or bipolar disorder, live on average 15-20 years less than the average person which is one of the key health inequalities people face in the UK and worldwide. But although programmes and initiatives have been created that aim to help people with severe mental illnesses take control of their health, these targeted interventions often fall short.

One major reason that people with severe mental illness live shorter lives on average, is because theyre more likely to suffer from physical health conditions. Not only does research show theyre twice as likely to have obesity, diabetes, or chronic obstructive pulmonary disease, theyre also 1.5 times more likely than the average person to have heart disease.

But socioeconomic status also has a major effect on how likely a person is to develop these conditions, including those with severe mental illnesses. Socioeconomic disadvantage such as having lower income, receiving less education, or living in a deprived area are all shown to be causes in developing chronic health conditions.

Not only does socioeconomic disadvantage appear to be a risk factor for developing mental disorders, research also shows that people with severe mental illness are 3.6 times more likely to live in the most socially deprived areas than the average.

Studies show that people living in deprived areas are also four to five times more likely to engage in unhealthy behaviours such as alcohol misuse, smoking, and having an unhealthy diet. All of these can lead to a range of long-term physical conditions, such as cancer or cardiovascular disease. On top of this, people with severe mental illness are also more likely to engage in risky behaviours that can lead to severe health complications.

Around 40% of adults with severe mental illness smoke, compared with just 15% of people in the general population. Theyre also three to four times more likely to misuse alcohol or drugs. However, these behaviours might reflect attempts to self-medicate. For example, people sometimes choose to smoke after starting new medication in order to counter the drugs effects on their metabolism, and decrease their appetite. Research does show that nicotine can increase how quickly your body processes antipsychotics, potentially reducing the intensity of their side-effects.

Read more: Having a severe mental illness often means dying before your time

People with severe mental illness are also more likely to have an unhealthy diet. This might be because medications can affect appetite and energy levels. One study found that people gained 12kg on average in the first 24 months after their diagnosis.

National guidance has been created which outlines how to help patients with mental illnesses improve their health. However, studies have shown large variations in whether these interventions are being offered by healthcare providers.

Its unclear why these differences exist, but earlier research suggested staff members didnt have enough support to follow these guidelines and put them into action. The lack of coordination between physical and mental healthcare systems might also be to blame.

Despite these guides, it can still be difficult to support people with severe mental illness in improving their health. Research found that healthcare staff didnt feel confident enough to support people with severe mental illness in quitting smoking. Many healthcare workers said they were concerned about the impact quitting would have on the patients mental health. Many people with severe mental illness even say smoking brings them pleasure, despite the long-term health risks.

But recent research shows that methods for quitting smoking are as effective in people with severe mental illness as the general population. And, tailored interventions that provided extra support to people with schizophrenia and bipolar disorder (such as longer sessions to prepare for quitting, and home visits) appeared to improve quitting rates.

Managing weight is also key in reducing early risk of death from health complications. One review found that nutrition interventions including group nutrition classes, help with shopping, and cooking classes reduced weight and body mass index. But attempts to replicate these results have failed in larger, high-quality trials for reasons that remain unclear. Weight loss can be challenging, as people may not know how to prepare healthy meals or exercise properly. It may also be difficult for people to travel to get fresh foods or take part in an exercise class while managing their mental health.

Personalised approached might be more effective, as unhealthy behaviours can cluster together. For example, if a person misuses alcohol, they might smoke too. Targeting these behaviours at the same time might lead to greater improvements than targeting them alone but the reverse might also be the case. For example, one study found that people who improved their diet or increased their level of physical activity were less likely to quit smoking.

New approaches such as analysing data collected by treatment services to track progress, using digital technology during interventions, and even promoting interaction with nature are some ways that might help improve the physical health of those with severe mental illness. People with severe mental illness are also increasingly working alongside researchers as partners to provide input and share their experiences rather than simply being study participants that are observed to collect data. This is important for making sure research delivers meaningful evidence that has real-world use and benefits.

But the problem with the severe mental illness label is that most studies have combined data on physical health risks for different mental health conditions (including psychosis, schizophrenia, and bipolar disorder). This fails to examine whether different conditions carry different risks.

It will be important for future research to work alongside participants with severe mental illness during high-quality trials to better understand what methods can help tackle this major health inequality.

Go here to read the rest:
People with severe mental illness live shorter lives but the solution isn't simple - The Conversation UK

Times of Trenton wrestling: Hamiltons Bennett wins, Allentowns Lamparelli loses in region action – nj.com

Posted: March 2, 2020 at 11:43 am

Hamilton's Ryan Bennett was the area's lone region champion on Saturday but the big news from the region action wasn't so much about who won but who lost.

Allentown's Joe Lamparelli, already a two time region champion, fell short of tying the CVC record of three region titles set by Steinert's two time state champion Brandon Cray when he lost to Middletown North's Fred Luchs 6-4 in overtime in the final of the NJSIAA/Rothman Orthopaedic Region 6 Tournament at Jackson Liberty.

At 40-6, Luchs is no slouch but considering Lamparelli came into the final at 39-0 and had defeated Luchs 9-3 in the District 22 final a week earlier, the loss had to be a disappointing one.

Lamparelli, who has just missed out on placing in the toughest weight class of the state tournament the past two years, will now face a tougher road to the elusive goal of medaling in Atlantic City. In a weight that includes several returning place winners, including last year's 113 pound state champion, Dean Peterson of St. John Vianney, the hit he is likely take in seeding from the loss will not help.

As unexpected as Lamparelli's finals defeat was, the lone area wrestler who claimed a region title also surprised as Bennett won the 170 pound championship at Region 6 after being seeded eighth in the weight.

Bennett, at 33-2 was an unlikely eighth seed but he quickly put the lie to that ranking when he knocked off the bracket's top seed, District 21 champion Brendan Newbury of Wall, 9-4 on Friday night in Jackson.

He cruised through his semifinal bout with a 12-4 decision over Burlington City's 4-seed James Ball and then completed his championship run with an 11-3 major decision in an all Mercer County final over Allentown's Paskal Miga.

Miga's path to the title match was just as littered with upset wins. The 10-seed Miga defeated 7-seed Connor Verga of Lawrence in Wednesday night's opening round and then buried 2-seed Anthony Bailey of Raritan in the first period of his Friday quarterfinal. Miga stamped his ticket to the final with a 7-3 semifinal win over 6-seed Jack Friedman of Long Branch.

In addition to Lamparelli and Miga, four other area wrestlers finished second in their regions. In Region 6, Northern Burlington's Brandon Totten avenged his surprising District 21 final loss to Wall's Cole Meyer by defeating Meyer in the semifinal at 113, 5-3. He lost in the final to top seeded and four time region championTyler Klinsky of Middletown North.

Allentown's Nick Golden also reached the final. Golden pinned his way through two rounds before falling in the final 3-2 to Red Bank Catholic's Sabino Portello, who won the championship out of the eighth seed.

Over in Region 5 at Franklin, both Princeton's James Romaine at 152 and Hopewell Valley's Christian Cacciabaudo at 220 were runners-up. While 3-seed Romaine came up short in the final in a 7-5 loss to top seed Michael McGee of Shore, he had an impressive tournament.

Romaine easily dispatched 6-seed Owen Fitzgerald of Middletown Southin the quarterfinals Friday night and then scored an impressive overtime win in the semifinals over 2-seed Anthony Romaniello of Hunterdon Central 11-10. Suffering through a late assault on top by Romaniello at the end of regulation, Romaine held on to force overtime and then parlayed a near fall in the second period of overtime to forge the victory.

Cacciabaudo, the sixth seed, was a sleeper at 220 as he surprised the weight's 3-seed, Joseph Porcaro of Sayreville 5-3 in the semifinals to earn his spot in the finals. He lost to 5-seed Michael Pavlinetz of Holmdel 7-2 in the final.

All of Hopewell's big three upper weights will be heading to Atlantic City as the two other members of the trio, 182 pounder Josh Beigman and Brian LaCross at 195 finished fourth in Region 5. Beigman, the fourth seed, had lost to top seed and eventual champion Blake Clayton of St. John Vianney in the semifinal while 5-seed La Cross lost his quarterfinal bout to 4-seed Alex Uryniak of North Hunterdon but wrestled all the way back to the consolation final.

Six other wrestlers will be heading to Atlantic City after placing fourth at Region 6. Hightstown produced three state qualifiers as Chris Stavrou at 195, Bryan Bonilla at 220 and Brenden Hansen at 285 all advanced, as did Allentown's Matt Paglia at 145 and Northern Burlington's Blake Geibel at 120.

Robbinsville's Drake Torrington caught a tough break in the seeding at 126, being stuck in the upper bracket with Freehold Boro's 1-seed Nico Messina. Still, 4-seed Torrington was able to defeat Wall's Mike Bruno 6-4 in the consolation semifinals to qualify for A.C.

Eight other area wrestlers placed at their regions but did not qualify for the state tournament. Hopewell Valley's Christian Micikas at 106 and Jacob Venezia at 113 both placed fifth at Region 5 while Northern Burlington's Brandon Rzuczek at 195 and Lawrence's Jake Dallarda at 160 and Mooamen Nasr at 285 finished fifth at Region 6.

Hightstowns Kether Thornton at 132 and Bordentowns Jason Baldorossi at 182 finished sixth in Region 6.

The rest is here:
Times of Trenton wrestling: Hamiltons Bennett wins, Allentowns Lamparelli loses in region action - nj.com

Castaneda Takes 1st at Girls’ Wrestling Invitational; Boys Send Five to State Open – Zip06.com

Posted: March 2, 2020 at 11:43 am

Girls Wrestling

East Haven sophomore Zayuri Castaneda earned a first-place finish at the inaugural Girls Wrestling Invitational last weekend. Zayuri took the gold in the 235-pound division while representing the Yellowjackets at the tournament, which was held at Floyd Little Athletic Center on Feb. 28 and 29.

Castaneda notched two pinfall victories on her way to winning her round-robin bracket at the invitational. In her first match, Castaneda pinned Natalia Morris of Trumbull in just 52 seconds. Castaneda went on to pin Ruby Camejo from New Haven at the 5:22 mark in her second bout.

Camejo then defeated Morris on a pin in the next contest. With her record of 2-0, Castaneda was crowned the first champion of the 235-pound division at the Girls Invitational.

Boys Wrestling

The Yellowjackets saw five athletes compete when the State Open Championship took place at Floyd Little Athletic Center on Feb. 28 and 29. East Haven scored 11 points to finish in a tie for 55th place at the meet.

Senior Alec DiVito won his first matchup via 3-2 decision before losing by 8-0 major decision in the quarterfinals of the 132-pound division. DiVito won his first consolation match by 7-3 decision and then lost his second match on 4-2 decision. DiVito entered the State Open on the heels of a first-place finish the 132-pound weight class at the Class M State Championship.

Senior Fabricio Bugatti won his opening bout of the 160-pound bracket by a 6-3 decision, after which he took a 5-0 loss in the second round. In his first consolation match, Bugatti dropped a 5-3 decision.

In the 126-pound division, junior Matt DiVito lost his first match by a 5-3 decision. DiVito won his first two consolation bouts by 8-4 and 13-9 decisions, respectively, then lost a 7-0 major decision in his next contest.

Senior Tanner DiVito came into the State Open after winning the 138-pound division at the Class M State Championship. DiVito lost a 10-8 decision in his first match at the Open, then came back to win an 11-3 major decision in his first consolation matchup. In his next bout, DiVito lost on a 3-0 decision.

Junior Tyler Kruse took a 5-1 loss in his opening bout. Kruse later lost a 9-1 major decision in his first consolation match.

Boys Ice Hockey

The East Haven co-op ice hockey team took three defeats during the last week of the regular to put its record at 8-12 entering the playoffs.

On Feb. 24, the Yellowjackets took a 5-2 home loss versus Guilford at Patsy DiLungo Ice Rink. East Haven had 2-0 lead after the first period before allowing the Indians to score five unanswered goals. Juniors Dave Amatruda and Cory Benni were the Yellowjackets goal scorers in the game.

Two days later, the Yellowjackets lost a 2-1 contest against Branford at Northford Ice Pavilion. Branford scored first, but East Haven quickly tied the game on a goal by Benni. The Hornets netted the go-ahead goal at the 5:29 mark of the second period and went on to get the 2-1 victory.

Then on Feb. 29, East Haven took an 8-2 defeat to Sheehan in its regular-season finale at Choate Ice Rink.

With their record of 5-2 in divisional play, the Yellowjackets have earned the No. 4 seed in the SCC/SWC Division II State Tournament. East Haven is playing top-seeded Branford in semifinal game at Bennett Rink on Thursday, March 5 at 7:30 p.m. With a victory, East Haven would face the winner of No. 2 seed Hand and No. 3 North Haven in the championship game at Bennett Rink at 4 p.m. on Saturday, March 7.

Following the conference tourney, East Haven will compete in the Division II State Tournament beginning with first-round action on Monday, March 9.

Boys Basketball

The Yellowjackets hosted Seymour for their last regular-season game on Feb. 27. East Haven dropped a 74-51 decision against the Wildcats to finish with a record of 4-16 on the year.

Boys Swimming and Diving

The Greater New Haven Warriors (GNH) boys swimming and diving team clinched the SCC Division 2 title by earning a home victory versus divisional opponent Sheehan in its regular-season finale on Senior Night. On Feb. 24, the Warriors hosted Sheehan and prevailed 100-70 at Walter Gawrych Community Pool to win the crown with a record of 6-0 in divisional meets. GNH finished with an overall mark of 8-2 for the regular season.

Later in the week, North Haven freshman Christian Butler earned a medal by finishing in sixth place at the SCC Diving Championship on behalf of the Warriors.

The Warriors honored North Haven student Stephen Borrelli and fellow senior captains Aidan Henry and Evan Laughlin of Guilford as part of their Senior Night festivities prior to their meet against Sheehan. Borrelli swam a lifetime-best time of 2:06.48 in the 200 freestyle in the victory. Henry went undefeated in the 50, 100, 200, and 500 freestyles during the regular season.

Junior Tanner Powell swam a lifetime best of 1:02.65 in the 100 butterfly for GNH. Junior Collin Romero turned in a lifetime best of 28.43 for the 50 freestyle, while freshman Patrick Cucchiarelli did a lifetime best in the 100 freestyle (59.60) to go with a season-best in the 100 backstroke (1:09.75).

Other swimmers who recorded season-best marks were junior Dan Kamen in the 200 individual medley (2:13.52), junior Cameron Cargan in the 200 freestyle (1:58.09); freshman Aiden Cohen (24.62), freshman Lucas Espinosa (26.03), and sophomore Miguel Pearce (26.19) in the 50 freestyle; and freshman RT Trotter in the 100 butterfly (1:05.34) and 100 breaststroke (1:18.01)

Butler posted a lifetime-best score of 209.80 for a six-dive routine during the Warriors win against Sheehan. Later in the week, Butler competed at the SCC Diving Championship and claimed sixth place by scoring 321.25 points for his 11-diving performance at Sheehan High School on Feb. 28. Butler scored points that will count toward the Warriors total when they swim at the SCC Championship this week.

After SCCs, GNH will compete in the Class LL State Championship, beginning with the Diving Championship at Middletown High School on Wednesday, March 11 at 5:30 p.m. The Class LL Swimming Trials will take place at East Hartford High School on Saturday, March 14 at 11:30 p.m., and the Class LL Swimming State Championship will be held at Wesleyan University on Tuesday, March 17 at 6 p.m.

Read the original here:
Castaneda Takes 1st at Girls' Wrestling Invitational; Boys Send Five to State Open - Zip06.com

These are the top 10 recruits in the state of Georgia – 247Sports

Posted: March 2, 2020 at 11:43 am

247Sports released its latest update to the Top247 Rankings for the 2021 class last week. It's one of several updates that will be made throughout the coming year with spring/summer camp evaluations, to go along with senior tape and All-American Bowl/Under Armour Game critiques that will ultimately decide the final rankings next January.

The state of Georgia is well represented in the update, with several top prospects among the Top247 at this juncture.

Here, Dawgs247 breaks down the top 10 recruits in the Peach State, according to the 247Sports Rankings.

Not a subscriber?Sign up nowto get access to everything Dawgs247 has to offer, including daily content from the largest staff covering Georgia athletics and access to the largest and most active community of Dawgs fans on the Web. Dont forget tosign up for our Dawgs247 Newsletter. Its free and a great way to get daily updates on Georgia football, basketball and more delivered straight to your inbox.Like uson Facebook.Follow uson Twitter.

Did you know Dawgs247 has a podcast? That's right folks. The Junkyard Dawgcast is available bringing you the best insight into the latest Georgia news from Rusty Mansell, Jake Rowe, and Kipp Adams. Catch the latest episoderight hereorsubscribe on iTunestoday!

Excerpt from:
These are the top 10 recruits in the state of Georgia - 247Sports

Skipping breakfast and snacking late at night could impact weight loss, new research suggests – Yahoo Sports

Posted: March 2, 2020 at 11:42 am

Skipping breakfast and snacking late at night could lead to a delay in the bodys ability to lose weight, new research has suggested.

If were trying to shed the pounds, we know we need to watch what we eat, how much we eat and how much we move, but according to a new study our ability to burn dietary calories could also be impacted by the time of day most of our food is consumed.

The study, published in the journalPLOS Biology,monitored the metabolism of middle-aged and older subjects in a whole-room respiratory chamber over two separate 56-hour sessions.

In each session, lunch and dinner were presented at the same times (12.30pm and 17.45pm, respectively), but the timing of the third meal differed between the two halves of the study.

Read more: The best diets for long-term health

In one of the 56-hour sessions, the additional daily meal was presented as breakfast (at 8:00) whereas in the other session, a nutritionally equivalent meal was given to the same subjects as a late-evening snack (22.00pm).

The duration of the overnight fast was the same for both sessions.

While the two sessions did not differ in the amount or type of food eaten, or in participants activity levels, the daily timing of the third meal had an impact on the amount of fat burned.

Researchers found that the late-evening snack session resulted in less fat burned when compared to the breakfast session.

Study authors said the circadian rhythm, or the body clock, is programmed to assist the body to burn fat when asleep.

As a consequence, skipping breakfast and then snacking at night could lead to a delay in the burning of the fat.

Based on their experimental observations, the researchers said the timing of meals during the day/night cycle could impact the extent to which ingested food is used versus stored.

The study team said their research could have wider implications for advising people on their eating habits, suggesting that a daily fast between the evening meal and breakfast could help optimise weight management.

Snacking late at night could have a negative impact on losing weight. (Getty)

Read more:The risks and benefits of veganism

This isnt the first time the health benefits of the overnight fast have been discussed.

Last year research suggested skippingbreakfast and eating a late dinner could lead to more serious outcomes after a heart attack.

Scientists found people who frequently bypassed brekkie and regularly ate dinner less than two hours before going to bed were far less likely to survive if they suffered a heart attack.

But there has also been some contradictory research in terms of whether eating breakfast can aid weight loss.

While eating breakfast has previously been thought to help aid weight loss, a further body of research suggests you may be better off without it.

Past studies have found aprotein-based morning meal or a bowl full ofoatsfirst thing could be the key to maintaining a steady weight and controlling your appetite later in the day.

Read more: Rosie Huntington-Whiteley reveals she doesn't eat after 6pm

But last year scientists from the Monash University in Melbourne found those who eat breakfast were found to have a higher energy consumption during the day (an average of 260 more calories) compared to those who skipped the morning meal.

Breakfast eaters also weighed, on average, almost half a kilogram more (0.44kg) compared to non-breakfast eaters.

Whats more, the scientists concluded skipping breakfast does not reduce appetite during the day, as previously thought.

The scientists werent the first to challenge the supposed link between eating breakfast and weight loss.

Followers of the popularintermittent fastingdiet will often skip breakfast in order to limit their eating window to later in the day.

See the rest here:
Skipping breakfast and snacking late at night could impact weight loss, new research suggests - Yahoo Sports


Page 951«..1020..950951952953..960970..»